Active Surveillance as an Effective Management Option for Low-Risk Papillary Thyroid Microcarcinoma
Endocrinology and Metabolism
;
: 717-724, 2021.
Artículo
en Inglés
| WPRIM
| ID: wpr-890497
ABSTRACT
Active surveillance (AS) for low-risk papillary thyroid microcarcinoma (PTMC) has been accepted worldwide as safe and effective. Despite the growing acceptance of AS in the management of low-risk PTMCs, there are barriers to AS in real clinical settings, and it is important to understand and establish appropriate AS protocol from initial evaluation to follow-up. PTMC management strategies should be decided upon after careful consideration of patient and tumor characteristics by a multidisciplinary team of thyroid cancer specialists. Patients should understand the risks and benefits of AS, participate in decision-making and follow structured monitoring strategies. In this review, we discuss clinical outcomes of AS from previous studies, optimal indications and follow-up strategies for AS, and unresolved questions about AS.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Tipo de estudio:
Estudio de etiología
/
Guía de Práctica Clínica
/
Estudio pronóstico
/
Estudio de tamizaje
Idioma:
Inglés
Revista:
Endocrinology and Metabolism
Año:
2021
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS